Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER1 | P34995 | 1/20 | 0.40 |
| ▸ | LRRK2 | Q5S007 | 11/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | PTGES | O14684 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | CCR5 | P51681 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29368013 | 1.00 | PTGER1 (0.40) | PTGER1LRRK2HPGDKDM4EALDH1A1 | |
| SCHEMBL22823736 | 1.00 | PTGER1 (0.40) | PTGER1LRRK2HPGDKDM4EALDH1A1 | |
| SCHEMBL29368644 | 0.89 | PTGDR2 (0.46) | PTGER1LRRK2HPGDKDM4EALDH1A1 | |
| SCHEMBL22824019 | 0.89 | PTGDR2 (0.46) | PTGER1LRRK2HPGDKDM4EALDH1A1 | |
| SCHEMBL29602289 | 0.89 | PTGDR2 (0.46) | PTGER1LRRK2HPGDKDM4EALDH1A1 | |
| SCHEMBL22823743 | 0.85 | SMN1; SMN2 (0.35) | HPGDALDH1A1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL28672381 | 0.85 | SMN1; SMN2 (0.35) | HPGDALDH1A1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL29368299 | 0.85 | SMN1; SMN2 (0.35) | HPGDALDH1A1NPC1RAB9ASMN1; SMN2 | |
| SCHEMBL22823975 | 0.81 | PPARA (0.37) | HPGDKDM4ENPC1RAB9ASMN1; SMN2 | |
| SCHEMBL29369333 | 0.81 | PPARA (0.37) | HPGDKDM4ENPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3986852-A1 | COMPOUNDS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS | NMD Pharma A/S (DK) | 2022-04-27 | — | — | EP | disclosed |
| CN-114008012-A | Compounds for the treatment of neuromuscular disorders | NMD制药股份公司 | 2022-02-01 | — | — | CN | disclosed |